companydata.dkcompanydata.dk

10x Genomics Denmark ApS: Financial statements 2021

CVR: 40243224

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

10x Genomics Denmark ApS (CVR 40243224) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 52,191,085 and a net result of DKK 39,803,587 compared with DKK -2,027,263 the year before. Equity in the 2021 report amounted to DKK 38,401,708. The solvency ratio was 76.3%. The company had 2 employees in the financial year.

Gross Profit
DKK 52,191,085
Profit/Loss
DKK 39,803,587
Equity
DKK 38,401,708
Total Assets
DKK 50,362,718
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-52.2 mio.39.8 mio.38.4 mio.2
2020--1.6 mio.-2 mio.-1.4 mio.2
2019-552 t.245 t.625 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like 10x Genomics Denmark ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

10x Genomics Denmark ApS: The 2020 annual report is outJun 24, 2021

10x Genomics Denmark ApS has published its annual report for 2020. Gross profit came to DKK -1,602,244, and the net result was DKK -2,027,263.

10x Genomics Denmark ApS appoints new auditorJan 8, 2021

As of January 8, 2021, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of 10x Genomics Denmark ApS.

Søren Fogh Aagaard leaves the board of 10x Genomics Denmark ApSJan 8, 2021

As of January 8, 2021, Søren Fogh Aagaard has left the board of directors of 10x Genomics Denmark ApS.

Søren Nyboe Jakobsen leaves the board of 10x Genomics Denmark ApSJan 8, 2021

As of January 8, 2021, Søren Nyboe Jakobsen has left the board of directors of 10x Genomics Denmark ApS.

Sunil Kumar Saini leaves the board of 10x Genomics Denmark ApSJan 8, 2021

As of January 8, 2021, Sunil Kumar Saini has left the board of directors of 10x Genomics Denmark ApS.

Sebastian Hartmut Springer leaves the board of 10x Genomics Denmark ApSJan 8, 2021

As of January 8, 2021, Sebastian Hartmut Springer has left the board of directors of 10x Genomics Denmark ApS.

Søren Nyboe Jakobsen joins 10x Genomics Denmark ApS as directorJan 8, 2021

As of January 8, 2021, Søren Nyboe Jakobsen is registered as director of 10x Genomics Denmark ApS.

Eric Stewart Whitaker joins 10x Genomics Denmark ApS as directorJan 8, 2021

As of January 8, 2021, Eric Stewart Whitaker is registered as director of 10x Genomics Denmark ApS.

Registered as owner of 10x Genomics Denmark ApSJan 8, 2021

As of January 8, 2021, is registered as an owner of 10x Genomics Denmark ApS with an ownership share of 100%.

Søren Nyboe Jakobsen steps down as adm. dir. of 10x Genomics Denmark ApSJan 7, 2021

As of January 7, 2021, Søren Nyboe Jakobsen has stepped down as adm. dir. of 10x Genomics Denmark ApS.

About 10x Genomics Denmark ApS

10x Genomics Denmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Tetramer Shop ApS. The management consists of Adam Samuel Taich and James Sears Bryant. The company is owned by 10x Genomics, Inc.. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,442,436 and a net result of DKK 154,956 compared with DKK 183,445 the year before. Equity in the 2025 report amounted to DKK 973,740.

Source: annual report 2025, Danish Business Authority

Other financial years